Description

Moxifloxacin Hydrochloride is a synthetic, broad-spectrum fluoroquinolone antibiotic agent. It is a critical active pharmaceutical ingredient (API) valued for its enhanced potency against a wide range of Gram-positive and Gram-negative bacteria, including atypical and anaerobic pathogens. This compound is essential for pharmaceutical manufacturers developing advanced ophthalmic solutions, oral tablets, and injectable formulations to treat serious bacterial infections such as community-acquired pneumonia, acute bacterial sinusitis, and bacterial conjunctivitis.

Application

Moxifloxacin Hydrochloride serves as the foundational active ingredient in a variety of advanced antimicrobial medications. Its primary and derived applications include:

• Ophthalmic Solutions: Formulation of eye drops for treating bacterial conjunctivitis and other ocular infections.
• Oral Solid Dosage Forms: Manufacture of tablets and capsules indicated for respiratory tract infections, skin infections, and intra-abdominal infections.
• Injectable Formulations: Production of intravenous (IV) solutions for hospital use in severe or systemic infections.
• Pharmaceutical Intermediates: Used in the synthesis of more complex drug substances or salt forms.
• Research & Development: Serves as a reference standard and key material in antimicrobial research and new drug development projects.
• Veterinary Pharmaceuticals: Potential use in developing antibacterial treatments for veterinary applications, subject to regional regulations.

Basic Information

Product Name	Moxifloxacin Hydrochloride
CAS No.	186826-86-8
Molecular Formula	C21H25FN3O4 • HCl
Molecular Weight	437.90 g/mol (as hydrochloride)
Synonyms	Moxifloxacin HCl; BAY 12-8039; 1-Cyclopropyl-7-[(1S,6S)-2,8-diazabicyclo[4.3.0]non-8-yl]-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride; Avelox (brand name API); Vigamox (brand name API); Moxifloxacine Hydrochloride; Moxifloxacinum Hydrochloridum
EINECS	Contact for details

Quality Control

Our Moxifloxacin Hydrochloride is produced and tested under strict quality management systems. We ensure compliance with major pharmacopoeial standards, including USP and EP monographs. Every batch undergoes comprehensive analytical testing for identity, purity, and impurity profiles. A Certificate of Analysis (COA) detailing specific results for assay, related substances, residual solvents, and microbiological quality is provided with each shipment to guarantee traceability and regulatory readiness.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and must be kept in a dry environment to prevent degradation. The original container should be kept sealed when not in use.

Specification

Item	Specification
Appearance	White to slightly yellow crystalline powder
Identification (IR)	Conforms
Identification (HPLC)	Conforms to reference standard
Assay (HPLC, anhydrous basis)	98.5% - 101.5%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Related Substances (HPLC)	Individual impurity ≤ 0.5%; Total impurities ≤ 1.5%
Heavy Metals	≤ 20 ppm
Microbial Enumeration	Meets EP/USP criteria

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.